Clinical Trial Update: Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of lubiprostone in irritable bowel syndrome with constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Irritable Bowel Syndrome

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Sucampo Pharma Americas, LLC | Conditions: Irritable Bowel Syndrome, Constipation | Phase 3 | Status: COMPLETED | Results posted: 2008-10-31